These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 31039730)

  • 1. Downregulation of lncRNA CCAT1 enhances 5-fluorouracil sensitivity in human colon cancer cells.
    Yang C; Pan Y; Deng SP
    BMC Mol Cell Biol; 2019 Apr; 20(1):9. PubMed ID: 31039730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Curcumin Reverses 5-Fluorouracil Resistance by Promoting Human Colon Cancer HCT-8/5-FU Cell Apoptosis and Down-regulating Heat Shock Protein 27 and P-Glycoprotein.
    He WT; Zhu YH; Zhang T; Abulimiti P; Zeng FY; Zhang LP; Luo LJ; Xie XM; Zhang HL
    Chin J Integr Med; 2019 Jun; 25(6):416-424. PubMed ID: 30484020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of Long Nonencoding Ribonucleic Acid SNHG20 in Colon Cancer Tissue in Its Influences on Chemotherapeutic Sensitivity of Colon Cancer Cells.
    Cao W; Zhang B; Liu Y
    Biomed Res Int; 2022; 2022():4752782. PubMed ID: 35915794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of rs67085638 in long non-coding RNA (CCAT1) on colon cancer chemoresistance to paclitaxel through modulating the microRNA-24-3p and FSCN1.
    Xiao ZS; Zhao L; Zhang XN; Li HX; Yin ZH
    J Cell Mol Med; 2021 Apr; 25(8):3744-3753. PubMed ID: 33709519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNA POU6F2-AS2 promotes cell proliferation and drug resistance in colon cancer by regulating miR-377/BRD4.
    Xu G; Zhu H; Xu J; Wang Y; Zhang Y; Zhang M; Zhu D
    J Cell Mol Med; 2020 Apr; 24(7):4136-4149. PubMed ID: 32100443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNA CCAT1 promotes human retinoblastoma SO-RB50 and Y79 cells through negative regulation of miR-218-5p.
    Zhang H; Zhong J; Bian Z; Fang X; Peng Y; Hu Y
    Biomed Pharmacother; 2017 Mar; 87():683-691. PubMed ID: 28088735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CX-3543 Promotes Cell Apoptosis through Downregulation of CCAT1 in Colon Cancer Cells.
    Yao YX; Xu BH; Zhang Y
    Biomed Res Int; 2018; 2018():9701957. PubMed ID: 30519593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spica Prunellae Extract Enhances Fluorouracil Sensitivity of 5-Fluorouracil-Resistant Human Colon Carcinoma HCT-8/5-FU Cells via TOP2
    Fang Y; Yang C; Zhang L; Wei L; Lin J; Zhao J; Peng J
    Biomed Res Int; 2019; 2019():5953619. PubMed ID: 31662984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bcl-XL small interfering RNA suppresses the proliferation of 5-fluorouracil-resistant human colon cancer cells.
    Zhu H; Guo W; Zhang L; Davis JJ; Teraishi F; Wu S; Cao X; Daniel J; Smythe WR; Fang B
    Mol Cancer Ther; 2005 Mar; 4(3):451-6. PubMed ID: 15767554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockdown of lncRNA CCAT1 enhances sensitivity of paclitaxel in prostate cancer via regulating miR-24-3p and FSCN1.
    Li X; Han X; Wei P; Yang J; Sun J
    Cancer Biol Ther; 2020 May; 21(5):452-462. PubMed ID: 32089062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. lncRNA KRAL reverses 5-fluorouracil resistance in hepatocellular carcinoma cells by acting as a ceRNA against miR-141.
    Wu L; Pan C; Wei X; Shi Y; Zheng J; Lin X; Shi L
    Cell Commun Signal; 2018 Aug; 16(1):47. PubMed ID: 30119680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. lncRNA CCAT1 is a biomarker for the proliferation and drug resistance of esophageal cancer via the miR-143/PLK1/BUBR1 axis.
    Hu M; Zhang Q; Tian XH; Wang JL; Niu YX; Li G
    Mol Carcinog; 2019 Dec; 58(12):2207-2217. PubMed ID: 31544294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early-stage colon cancer with high MALAT1 expression is associated with the 5-Fluorouracil resistance and future metastasis.
    Ak Aksoy S; Tunca B; Erçelik M; Tezcan G; Ozturk E; Cecener G; Ugras N; Yilmazlar T; Yerci O
    Mol Biol Rep; 2022 Dec; 49(12):11243-11253. PubMed ID: 35794508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knockdown of lncRNA CCAT1 Inhibits the Progression of Colorectal Cancer via hsa-miR-4679 Mediating the Downregulation of GNG10.
    Wang N; Li J; He J; Jing YG; Zhao WD; Yu WJ; Wang J
    J Immunol Res; 2021; 2021():8930813. PubMed ID: 35005034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression of Runt-related Transcription Factor 3 in Human Colon Cancer Cell Line HCT-116 Resistant to 5-Fluorouracil and the Mechanism of Drug Resistance].
    Fan S; Wu XL; Xue J; Xu DD; Han YJ; Li YR; Qu M
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2021 Oct; 43(5):706-715. PubMed ID: 34728031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of selective cyclooxygenase-2 inhibitor NS-398 on 5-fluorouracil chemotherapy and progression of colon cells: an experimental study].
    Zhang YC; Wang S; Zhang H; Ye YJ; Liang B; Cui ZR
    Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):583-6. PubMed ID: 15144595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C-Myc-activated long noncoding RNA CCAT1 promotes colon cancer cell proliferation and invasion.
    He X; Tan X; Wang X; Jin H; Liu L; Ma L; Yu H; Fan Z
    Tumour Biol; 2014 Dec; 35(12):12181-8. PubMed ID: 25185650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The c-MYC-ABCB5 axis plays a pivotal role in 5-fluorouracil resistance in human colon cancer cells.
    Kugimiya N; Nishimoto A; Hosoyama T; Ueno K; Enoki T; Li TS; Hamano K
    J Cell Mol Med; 2015 Jul; 19(7):1569-81. PubMed ID: 25689483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knockdown of PRDX2 sensitizes colon cancer cells to 5-FU by suppressing the PI3K/AKT signaling pathway.
    Xu J; Zhang S; Wang R; Wu X; Zeng L; Fu Z
    Biosci Rep; 2017 Jun; 37(3):. PubMed ID: 28432271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of cIAP2 enhances 5-FU sensitivity through the apoptotic pathway in human colon cancer cells.
    Karasawa H; Miura K; Fujibuchi W; Ishida K; Kaneko N; Kinouchi M; Okabe M; Ando T; Murata Y; Sasaki H; Takami K; Yamamura A; Shibata C; Sasaki I
    Cancer Sci; 2009 May; 100(5):903-13. PubMed ID: 19302291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.